Adcetris 50mg Injection

Adcetris 50mg injection is an anticancer medication that belongs to the CD30 monoclonal antibodies category containing the active ingredient Brentuximab vedotin. This medication is used to treat certain types of cancer, including classical Hodgkin lymphoma (cancer of the lymphatic system), cutaneous T-cell lymphoma (a type of non-Hodgkin lymphoma that affects the skin), and systemic anaplastic large-cell lymphoma (abnormal growth of T-lymphocytes). This drug is an antibody-drug conjugate (ADC) that targets cancer cells specifically. It may be used as a frontline treatment or when other treatments are ineffective.

Treatment of Hodgkin’s disease

Adcetris 50mg injection can be administered only as an intravenous injection into a vein by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

Adcetris 50mg injection consists of an antibody that targets CD30, a protein found on the surface of cancer cells, and a chemotherapy drug that is attached to the antibody. The antibody delivers the chemotherapy directly to the cancer cells, minimizing damage to healthy cells.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

cold chain

1 vial